We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Intellia Therapeutics Inc | NASDAQ:NTLA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 1.19% | 21.23 | 21.22 | 21.24 | 21.4699 | 20.98 | 21.14 | 354,786 | 16:36:47 |
CUSIP No. 45826J105
|
||||
1
|
NAME OF REPORTING PERSONS
OrbiMed Advisors LLC
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
☐
(b)
☐
|
|||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
2,537,684
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
2,537,684
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,537,684
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(See Instructions) |
☐
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.99%*
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
IA
|
|||
CUSIP No. 45826J105
|
||||
1
|
NAME OF REPORTING PERSONS
OrbiMed Capital GP V LLC
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
☐
(b)
☐
|
|||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
1,943,388
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
1,943,388
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,943,388
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(See Instructions) |
☐
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.59%*
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
OO
|
|||
CUSIP No. 45826J105
|
||||
1
|
NAME OF REPORTING PERSONS
OrbiMed Global Healthcare GP LLC
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
☐
(b)
☐
|
|||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
594,296
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
594,296
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
594,296
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(See Instructions) |
☐
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.40%*
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
OO
|
|||
Item 1.
|
Security and Issuer
|
Item 2.
|
Identity and Background
|
Item 5.
|
Interest in Securities of the Issuer
|
Item 6.
|
Contracts, Arrangements, Understandings or Relationship with Respect to Securities of the Issuer
|
Item 7.
|
Materials to Be Filed as Exhibits
|
Exhibit
|
Description
|
1.
|
Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP V LLC, and OrbiMed Global Healthcare GP LLC.
|
|
OrbiMed Advisors LLC
|
|||
|
||||
|
By:
|
/s/ Jonathan T. Silverstein
|
||
|
|
Name:
|
Jonathan T. Silverstein
|
|
|
|
Title:
|
Member of OrbiMed Advisors LLC
|
|
|
|
|||
|
By:
|
/s/ Sven H. Borho
|
||
|
|
Name:
|
Sven H. Borho
|
|
|
|
Title:
|
Member of OrbiMed Advisors LLC
|
|
|
|
|||
|
By:
|
/s/ Carl L. Gordon
|
||
|
|
Name:
|
Carl L. Gordon
|
|
|
|
Title:
|
Member of OrbiMed Advisors LLC
|
|
|
|
|||
|
|
|||
|
OrbiMed Capital GP V LLC
|
|||
|
|
|||
|
By:
|
OrbiMed Advisors LLC
its Managing Member |
||
|
|
|||
|
|
|||
|
By:
|
/s/ Jonathan T. Silverstein
|
||
|
|
Name:
|
Jonathan T. Silverstein
|
|
|
|
Title:
|
Member of OrbiMed Advisors LLC
|
|
|
By:
|
/s/ Sven H. Borho
|
||
|
|
Name:
|
Sven H. Borho
|
|
|
|
Title:
|
Member of OrbiMed Advisors LLC
|
|
|
|
|||
|
By:
|
/s/ Carl L. Gordon
|
||
|
|
Name:
|
Carl L. Gordon
|
|
|
|
Title:
|
Member of OrbiMed Advisors LLC
|
|
|
OrbiMed
Global Healthcare GP LLC
|
|||
|
|
|
||
|
By:
|
OrbiMed Advisors LLC
its Managing Member
|
||
|
|
|
||
|
|
|
||
|
By:
|
/s/ Jonathan T. Silverstein
|
||
|
Name:
|
Jonathan T. Silverstein
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
||
|
By:
|
/s/ Sven H. Borho
|
||
|
Name:
|
Sven H. Borho
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
|
|
||
|
By:
|
/s/ Carl L. Gordon
|
||
|
Name:
|
Carl L. Gordon
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
Name
|
Position with Reporting
Person |
Principal Occupation
|
Samuel D. Isaly
|
Managing Member
|
Managing Member
OrbiMed Advisors LLC |
Carl L. Gordon
|
Member
|
Member
OrbiMed Advisors LLC |
Sven H. Borho
German and Swedish Citizen |
Member
|
Member
OrbiMed Advisors LLC |
Jonathan T. Silverstein
|
Member
|
Member
OrbiMed Advisors LLC |
W. Carter Neild
|
Member
|
Member
OrbiMed Advisors LLC |
Geoffrey C. Hsu
|
Member
|
Member
OrbiMed Advisors LLC |
Evan D. Sotiriou
|
Chief Financial Officer
|
Chief Financial Officer
OrbiMed Advisors LLC |
Exhibit
|
Description
|
1.
|
Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP V LLC, and OrbiMed Global Healthcare GP LLC.
|
1 Year Intellia Therapeutics Chart |
1 Month Intellia Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions